Bhanji Muna — SEC insider filings

SEC reporting owner CIK 1846905. 44 insider filings on record with FilingPulse; latest filed 2026-10-20.

Transaction summary — filings shown

Covers all 44 filings on record, filed 2021-02-18 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERACYTE, INC. (VCYT)Director13—8 legs · 21,158 sh · $590,5336
CYTOKINETICS INC (CYTK)Director14—3 legs · 5,454 sh · $215,60217
Intellia Therapeutics, Inc. (NTLA)Director11—5 legs · 2,927 sh · $95,81912
ARDELYX, INC. (ARDX)Director6——9

Insider filings — Bhanji Muna

FiledFormIssuerReported transactionsSource
2026-10-204VERACYTE, INC. (VCYT)Sale (S): 1,864 @ $43.70EDGAR
2026-09-034VERACYTE, INC. (VCYT)Sale (S): 1,864 @ $42.97EDGAR
2026-06-184ARDELYX, INC. (ARDX)Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0EDGAR
2026-06-154VERACYTE, INC. (VCYT)Grant/award (A): 5,272 @ $0EDGAR
2026-06-104Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 9,200 @ $0 · Grant/award (A): 13,300 (derivative) @ $0EDGAR
2026-05-274CYTOKINETICS INC (CYTK)Grant/award (A): 2,851 @ $0 · Grant/award (A): 4,301 (derivative) @ $0EDGAR
2025-06-234VERACYTE, INC. (VCYT)Grant/award (A): 9,321 @ $0EDGAR
2025-06-234ARDELYX, INC. (ARDX)Grant/award (A): 41,551 @ $0 · Grant/award (A): 54,059 (derivative) @ $0EDGAR
2025-06-174VERACYTE, INC. (VCYT)Sale (S): 4,589 @ $26.67EDGAR
2025-06-134Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 8,000 @ $0 · Grant/award (A): 11,450 (derivative) @ $0EDGAR
2025-05-154CYTOKINETICS INC (CYTK)Sale (S): 1,454 @ $29.73EDGAR
2025-05-144CYTOKINETICS INC (CYTK)Grant/award (A): 7,333 @ $0 · Grant/award (A): 10,880 (derivative) @ $0EDGAR
2025-05-014Intellia Therapeutics, Inc. (NTLA)Sale (S): 265 @ $8.50EDGAR
2025-01-314Intellia Therapeutics, Inc. (NTLA)Sale (S): 265 @ $9.97EDGAR
2024-06-174VERACYTE, INC. (VCYT)Grant/award (A): 11,473 @ $0EDGAR
2024-06-174ARDELYX, INC. (ARDX)Grant/award (A): 40,243 (derivative) @ $0EDGAR
2024-06-144Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 7,737 @ $0 · Grant/award (A): 11,515 (derivative) @ $0EDGAR
2024-06-114VERACYTE, INC. (VCYT)Sale (S): 3,870 @ $20.32EDGAR
2024-06-104CYTOKINETICS INC (CYTK)Sale (S): 2,000 @ $52.07EDGAR
2024-05-304VERACYTE, INC. (VCYT)Sale (S): 1,539 @ $21EDGAR
2024-05-164CYTOKINETICS INC (CYTK)Grant/award (A): 5,600 @ $0 · Grant/award (A): 3,636 (derivative) @ $0EDGAR
2023-11-024Intellia Therapeutics, Inc. (NTLA)Sale (S): 265 @ $23.90EDGAR
2023-08-024Intellia Therapeutics, Inc. (NTLA)Sale (S): 265 @ $42.33EDGAR
2023-07-104Intellia Therapeutics, Inc. (NTLA)Sale (S): 1,867 @ $39.30EDGAR
2023-07-074CYTOKINETICS INC (CYTK)Sale (S): 2,000 @ $34.12EDGAR
2023-06-214VERACYTE, INC. (VCYT)Sale (S): 5,793 @ $26.42 · Sale (S): 100 @ $27.09EDGAR
2023-06-164ARDELYX, INC. (ARDX)Grant/award (A): 49,237 (derivative) @ $0EDGAR
2023-06-164Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 4,425 @ $0 · Grant/award (A): 6,473 (derivative) @ $0EDGAR
2023-06-134VERACYTE, INC. (VCYT)Grant/award (A): 9,674 @ $0EDGAR
2023-06-014VERACYTE, INC. (VCYT)Sale (S): 1,539 @ $25.91EDGAR
2023-05-184CYTOKINETICS INC (CYTK)Grant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-10-054CYTOKINETICS INC (CYTK)Grant/award (A): 220 @ $51.11EDGAR
2022-07-124CYTOKINETICS INC (CYTK)Grant/award (A): 274 @ $41EDGAR
2022-06-174ARDELYX, INC. (ARDX)Grant/award (A): 95,802 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-06-164VERACYTE, INC. (VCYT)Grant/award (A): 14,731 @ $0EDGAR
2022-06-164Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 2,014 @ $0 · Grant/award (A): 2,980 (derivative) @ $0EDGAR
2022-05-114CYTOKINETICS INC (CYTK)Grant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-05-024Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 7,954 @ $0 · Grant/award (A): 11,700 (derivative) @ $0EDGAR
2022-04-014CYTOKINETICS INC (CYTK)Grant/award (A): 293 @ $38.38EDGAR
2022-01-044CYTOKINETICS INC (CYTK)Grant/award (A): 244 @ $46EDGAR
2021-05-134CYTOKINETICS INC (CYTK)Grant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-03-234VERACYTE, INC. (VCYT)Grant/award (A): 11,541 @ $0EDGAR
2021-03-154ARDELYX, INC. (ARDX)Grant/award (A): 63,687 (derivative) @ $0EDGAR
2021-02-184CYTOKINETICS INC (CYTK)Grant/award (A): 35,000 (derivative) @ $21.86EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1846905 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs